Loading clinical trials...
Loading clinical trials...
A Multi-centre, Double Blind, Randomised, Placebo Controlled, Parallel Group Study Investigating Simvastatin as an Add-on Treatment IM Administered Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
Conditions
Interventions
Interferon-beta-1a
Simvastatin
+1 more
Locations
1
Denmark
Coordinating Research Site
Copenhagen, Denmark
Start Date
February 1, 2006
Primary Completion Date
April 1, 2010
Completion Date
April 1, 2010
Last Updated
October 15, 2010
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07376772
NCT07426991
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions